HIV tedavisinde Vx478, Zidovüdin, FTC ve/veya 3TC içeren kombinasyonlarin kullanimi

HIV tedavisinde Vx478, Zidovüdin, FTC ve/veya 3TC içeren kombinasyonlarin kullanimi

Bu bulus anti HIV aktiviteye haiz The present invention relates to therapeutic combinations of 3S-[3R*(1R*,2S*)-[3 -[[(4-aminophenyl)sulphonyl](2-methylpropyl)-amino]-2-hydroxy-1-phenylmethyl)propyl]carbamic acid, tetrahydro-3-furanyl ester (141W94), 3'-azido-3'-deoxythymidine (zidovudine)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MARTHA HEIDER ST.CLAIR, DAVID WALTER BARRY
Format: Patent
Sprache:tur
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MARTHA HEIDER ST.CLAIR
DAVID WALTER BARRY
description Bu bulus anti HIV aktiviteye haiz The present invention relates to therapeutic combinations of 3S-[3R*(1R*,2S*)-[3 -[[(4-aminophenyl)sulphonyl](2-methylpropyl)-amino]-2-hydroxy-1-phenylmethyl)propyl]carbamic acid, tetrahydro-3-furanyl ester (141W94), 3'-azido-3'-deoxythymidine (zidovudine) and (2R, cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (3TC) (or, alternatively to 3TC, (2R,cis)-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (FTC) which have anti-HIV activity. The present invention is also concerned with pharmaceutical compositions containing said combinations and their use in the treatment of HIV infections including infections with HIV mutants bearing resistance to nucleoside and/or non-nucleoside inhibitors.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TR199802704TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TR199802704TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TR199802704TT23</originalsourceid><addsrcrecordid>eNrjZAj18AxTKElNSSzLLM7MS0lVCKswMbfQUYjKTMkvO7wnJTNPR8EtxFmhLFW_LLUyUcEYyM48vDy1KDVPITs_NykzL7G4Mj8vJ7EoEyhQmpOTmJeZm8nDwJqWmFOcyguluRmU3VxDnD10Uwvy41OLCxKTU_NSS-JDggwtLS0MjMwNTEJCjIyJUwUAanA6Ow</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HIV tedavisinde Vx478, Zidovüdin, FTC ve/veya 3TC içeren kombinasyonlarin kullanimi</title><source>esp@cenet</source><creator>MARTHA HEIDER ST.CLAIR ; DAVID WALTER BARRY</creator><creatorcontrib>MARTHA HEIDER ST.CLAIR ; DAVID WALTER BARRY</creatorcontrib><description>Bu bulus anti HIV aktiviteye haiz The present invention relates to therapeutic combinations of 3S-[3R*(1R*,2S*)-[3 -[[(4-aminophenyl)sulphonyl](2-methylpropyl)-amino]-2-hydroxy-1-phenylmethyl)propyl]carbamic acid, tetrahydro-3-furanyl ester (141W94), 3'-azido-3'-deoxythymidine (zidovudine) and (2R, cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (3TC) (or, alternatively to 3TC, (2R,cis)-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (FTC) which have anti-HIV activity. The present invention is also concerned with pharmaceutical compositions containing said combinations and their use in the treatment of HIV infections including infections with HIV mutants bearing resistance to nucleoside and/or non-nucleoside inhibitors.</description><edition>6</edition><language>tur</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1999</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19990322&amp;DB=EPODOC&amp;CC=TR&amp;NR=199802704T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19990322&amp;DB=EPODOC&amp;CC=TR&amp;NR=199802704T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MARTHA HEIDER ST.CLAIR</creatorcontrib><creatorcontrib>DAVID WALTER BARRY</creatorcontrib><title>HIV tedavisinde Vx478, Zidovüdin, FTC ve/veya 3TC içeren kombinasyonlarin kullanimi</title><description>Bu bulus anti HIV aktiviteye haiz The present invention relates to therapeutic combinations of 3S-[3R*(1R*,2S*)-[3 -[[(4-aminophenyl)sulphonyl](2-methylpropyl)-amino]-2-hydroxy-1-phenylmethyl)propyl]carbamic acid, tetrahydro-3-furanyl ester (141W94), 3'-azido-3'-deoxythymidine (zidovudine) and (2R, cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (3TC) (or, alternatively to 3TC, (2R,cis)-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (FTC) which have anti-HIV activity. The present invention is also concerned with pharmaceutical compositions containing said combinations and their use in the treatment of HIV infections including infections with HIV mutants bearing resistance to nucleoside and/or non-nucleoside inhibitors.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1999</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAj18AxTKElNSSzLLM7MS0lVCKswMbfQUYjKTMkvO7wnJTNPR8EtxFmhLFW_LLUyUcEYyM48vDy1KDVPITs_NykzL7G4Mj8vJ7EoEyhQmpOTmJeZm8nDwJqWmFOcyguluRmU3VxDnD10Uwvy41OLCxKTU_NSS-JDggwtLS0MjMwNTEJCjIyJUwUAanA6Ow</recordid><startdate>19990322</startdate><enddate>19990322</enddate><creator>MARTHA HEIDER ST.CLAIR</creator><creator>DAVID WALTER BARRY</creator><scope>EVB</scope></search><sort><creationdate>19990322</creationdate><title>HIV tedavisinde Vx478, Zidovüdin, FTC ve/veya 3TC içeren kombinasyonlarin kullanimi</title><author>MARTHA HEIDER ST.CLAIR ; DAVID WALTER BARRY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TR199802704TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>tur</language><creationdate>1999</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MARTHA HEIDER ST.CLAIR</creatorcontrib><creatorcontrib>DAVID WALTER BARRY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MARTHA HEIDER ST.CLAIR</au><au>DAVID WALTER BARRY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HIV tedavisinde Vx478, Zidovüdin, FTC ve/veya 3TC içeren kombinasyonlarin kullanimi</title><date>1999-03-22</date><risdate>1999</risdate><abstract>Bu bulus anti HIV aktiviteye haiz The present invention relates to therapeutic combinations of 3S-[3R*(1R*,2S*)-[3 -[[(4-aminophenyl)sulphonyl](2-methylpropyl)-amino]-2-hydroxy-1-phenylmethyl)propyl]carbamic acid, tetrahydro-3-furanyl ester (141W94), 3'-azido-3'-deoxythymidine (zidovudine) and (2R, cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (3TC) (or, alternatively to 3TC, (2R,cis)-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (FTC) which have anti-HIV activity. The present invention is also concerned with pharmaceutical compositions containing said combinations and their use in the treatment of HIV infections including infections with HIV mutants bearing resistance to nucleoside and/or non-nucleoside inhibitors.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language tur
recordid cdi_epo_espacenet_TR199802704TT2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title HIV tedavisinde Vx478, Zidovüdin, FTC ve/veya 3TC içeren kombinasyonlarin kullanimi
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T23%3A22%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MARTHA%20HEIDER%20ST.CLAIR&rft.date=1999-03-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETR199802704TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true